Farnesol and Selected Nanoparticles (Silver, Gold, Copper, and Zinc Oxide) as Effective Agents Against Biofilms Formed by Pathogenic Microorganisms

References

• Maier B. How physical interactions shape bacterial biofilms. Annu Rev Biophys. 2021;50(1):401–417. doi:10.1146/annurev-biophys-062920-063646
   PubMedGoogle Scholar
• Wong GCL, Antani JD, Lele PP, et al. Roadmap on emerging concepts in the physical biology of bacterial biofilms: from surface sensing to community formation. Phys Biol. 2021;18(5). doi:10.1088/1478-3975/ABDC0E
   PubMed Web of Science ®Google Scholar
• Funari R, Shen AQ. Detection and characterization of bacterial biofilms and biofilm-based sensors. ACS Sens. 2022;7(2):347–357. doi:10.1021/ACSSENSORS.1C02722/ASSET/IMAGES/LARGE/SE1C02722_0003.JPEG
   PubMed Web of Science ®Google Scholar
• Garrett TR, Bhakoo M, Zhang Z. Bacterial adhesion and biofilms on surfaces. Prog Nat Sci. 2008;18(9):1049–1056. doi:10.1016/j.pnsc.2008.04.001
   Web of Science ®Google Scholar
• Preda VG, Săndulescu O. Communication is the key: biofilms, quorum sensing, formation and prevention. Discoveries. 2019;7(3):e10. doi:10.15190/d.2019.13
   Google Scholar
• Goldberg J. Biofilms and antibiotic resistance: a genetic linkage. Trends Microbiol. 2002;10(6):264. doi:10.1016/S0966-842X(02)02381-8
   Web of Science ®Google Scholar
• Peng J-S, Tsai W-C, Chou -C-C. Inactivation and removal of Bacillus cereus by sanitizer and detergent. Int J Food Microbiol. 2002;77(1–2):11–18. doi:10.1016/S0168-1605(02)00060-0
   PubMed Web of Science ®Google Scholar
• Chen MJ, Zhang Z, Bott TR. Direct measurement of the adhesive strength of biofilms in pipes by micromanipulation. Biotechnol Tech. 1998;12(12):875–880. doi:10.1023/A:1008805326385/METRICS
   Google Scholar
• Flemming H-C, Neu TR, Wozniak DJ. The EPS matrix: the house of biofilm cells. J Bacteriol. 2007;189(22):7945–7947. doi:10.1128/JB.00858-07
   PubMed Web of Science ®Google Scholar
• Kim J, Hahn J-S, Franklin MJ, Stewart PS, Yoon J. Tolerance of dormant and active cells in Pseudomonas aeruginosa PA01 biofilm to antimicrobial agents. J Antimicrob Chemother. 2009;63(1):129–135. doi:10.1093/jac/dkn462
   PubMed Web of Science ®Google Scholar
• Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov. 2003;2(2):114–122. doi:10.1038/nrd1008
   PubMed Web of Science ®Google Scholar
• Dalton HM, March PE. Molecular genetics of bacterial attachment and biofouling. Curr Opin Biotechnol. 1998;9(3):252–255. doi:10.1016/S0958-1669(98)80055-4
   PubMed Web of Science ®Google Scholar
• Carrascosa C, Raheem D, Ramos F, Saraiva A, Raposo A. Microbial biofilms in the food industry—a comprehensive review. Int J Environ Res Public Health. 2021;18(4):2014. doi:10.3390/ijerph18042014
   PubMed Web of Science ®Google Scholar
• Azanchi T, Shafaroodi H, Asgarpanah J. Anticonvulsant activity of Citrus aurantium blossom essential oil (neroli): involvement of the GABAergic system. Nat Prod Commun. 2014;9(11):1615–1618.
   PubMed Web of Science ®Google Scholar
• Krupčík J, Gorovenko R, Špánik I, Sandra P, Armstrong DW. Enantioselective comprehensive two-dimensional gas chromatography. A route to elucidate the authenticity and origin of Rosa damascena Miller essential oils. J Sep Sci. 2015;38(19):3397–3403. doi:10.1002/jssc.201500744
   PubMed Web of Science ®Google Scholar
• Jung Y, Hwang S, Sethi G, Fan L, Arfuso F, Ahn K. Potential anti-inflammatory and anti-cancer properties of farnesol. Molecules. 2018;23(11):2827. doi:10.3390/molecules23112827
   PubMed Web of Science ®Google Scholar
• Joo JH, Jetten AM. Molecular mechanisms involved in farnesol-induced apoptosis. Cancer Lett. 2010;287(2):123–135. doi:10.1016/j.canlet.2009.05.015
   PubMed Web of Science ®Google Scholar
• Sato T, Watanabe T, Mikami T, Matsumoto T. Farnesol, a morphogenetic autoregulatory substance in the dimorphic fungus Candida albicans, inhibits hyphae growth through suppression of a mitogen-activated protein kinase cascade. Biol Pharm Bull. 2004;27(5):751–752. doi:10.1248/bpb.27.751
   PubMed Web of Science ®Google Scholar
• Yar N, Wittman E, Schaut D, Seta F. Effects of farnesol on drug-resistant and non-resistant Candida albicans: implications for cosmetic and pharmaceutical applications. Adv Microbiol. 2020;10(08):383–396. doi:10.4236/aim.2020.108028
   Google Scholar
• Koo H. Inhibition of Streptococcus mutans biofilm accumulation and polysaccharide production by apigenin and tt-farnesol. J Antimicrob Chemother. 2003;52(5):782–789. doi:10.1093/jac/dkg449
   PubMed Web of Science ®Google Scholar
• Ivanova A, Ivanova K, Fiandra L, et al. Antibacterial, antibiofilm, and antiviral farnesol-containing nanoparticles prevent Staphylococcus aureus from drug resistance development. Int J Mol Sci. 2022;23(14):7527. doi:10.3390/ijms23147527
   PubMed Web of Science ®Google Scholar
• Inoue Y, Shiraishi A, Hada T, Hirose K, Hamashima H, Shimada J. The antibacterial effects of terpene alcohols on Staphylococcus aureus and their mode of action. FEMS Microbiol Lett. 2004;237(2):325–331. doi:10.1111/j.1574-6968.2004.tb09714.x
   PubMed Web of Science ®Google Scholar
• Ramage G, Saville SP, Wickes BL, López-Ribot JL. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol. 2002;68(11):5459–5463. doi:10.1128/AEM.68.11.5459-5463.2002/ASSET/962BC315-0B68-447D-98C7-A45C742CEE16/ASSETS/GRAPHIC/AM1120413003.JPEG
   PubMed Web of Science ®Google Scholar
• Decanis N. Farnesol, a fungal quorum-sensing molecule triggers Candida albicans morphological changes by downregulating the expression of different secreted aspartyl proteinase genes. Open Microbiol J. 2011;5(1):119–126. doi:10.2174/1874285801105010119
   PubMedGoogle Scholar
• Sims KR, Liu Y, Hwang G, Jung HI, Koo H, Benoit DSW. Enhanced design and formulation of nanoparticles for anti-biofilm drug delivery. Nanoscale. 2019;11(1):219–236. doi:10.1039/C8NR05784B
   Web of Science ®Google Scholar
• Vimbela G, Ngo S, Fraze C, Yang L, Stout DA. Antibacterial properties and toxicity from metallic nanomaterials [Corrigendum]. Int J Nanomed. 2018;13:6497–6498. doi:10.2147/IJN.S183907
   PubMed Web of Science ®Google Scholar
• Bruna T, Maldonado-Bravo F, Jara P, Caro N. Silver nanoparticles and their antibacterial applications. Int J Mol Sci. 2021;22(13). doi:10.3390/ijms22137202
   Web of Science ®Google Scholar
• Mammari N, Lamouroux E, Boudier A, Duval RE. Current knowledge on the oxidative-stress-mediated antimicrobial properties of metal-based nanoparticles. Microorg. 2022;10(2):437. doi:10.3390/MICROORGANISMS10020437
   PubMed Web of Science ®Google Scholar
• Ananth A, Dharaneedharan S, Heo MS, Mok YS. Copper oxide nanomaterials: synthesis, characterization and structure-specific antibacterial performance. Chem Eng J. 2015;262:179–188. doi:10.1016/J.CEJ.2014.09.083
   Web of Science ®Google Scholar
• Lange A, Grzenia A, Wierzbicki M, et al. Silver and copper nanoparticles inhibit biofilm formation by mastitis pathogens. Anim. 2021;11(7):1884. doi:10.3390/ANI11071884
   Google Scholar
• Gupta D, Singh A, Khan AU. Nanoparticles as efflux pump and biofilm inhibitor to rejuvenate bactericidal effect of conventional antibiotics. Nanoscale Res Lett. 2017;12. doi:10.1186/S11671-017-2222-6
   PubMed Web of Science ®Google Scholar
• Sánchez-López E, Gomes D, Esteruelas G, et al. Metal-based nanoparticles as antimicrobial agents: an overview. Nanomater. 2020;10(2):292. doi:10.3390/NANO10020292
   Web of Science ®Google Scholar
• Medici S, Peana M, Pelucelli A, Zoroddu MA. An updated overview on metal nanoparticles toxicity. Semin Cancer Biol. 2021;76:17–26. doi:10.1016/J.SEMCANCER.2021.06.020
   PubMed Web of Science ®Google Scholar
• Danaei M, Dehghankhold M, Ataei S, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharm. 2018;10(2):57. doi:10.3390/PHARMACEUTICS10020057
   Google Scholar
• Takechi-Haraya Y, Ohgita T, Demizu Y, Saito H, Izutsu K, Sakai-Kato K. Current status and challenges of analytical methods for evaluation of size and surface modification of nanoparticle-based drug formulations. AAPS Pharm Sci Tech. 2022;23(5):150. doi:10.1208/s12249-022-02303-y
   PubMed Web of Science ®Google Scholar
• Xu L, Liang HW, Yang Y, Yu SH. Stability and reactivity: positive and negative aspects for nanoparticle processing. Chem Rev. 2018;118(7):3209–3250. doi:10.1021/ACS.CHEMREV.7B00208/ASSET/IMAGES/MEDIUM/CR-2017-00208M_0040.GIF
   PubMed Web of Science ®Google Scholar
• Slavin YN, Asnis J, Häfeli UO, Bach H. Metal nanoparticles: understanding the mechanisms behind antibacterial activity. J Nanobiotechnology. 2017;15(1):1–20. doi:10.1186/S12951-017-0308-Z/FIGURES/4
   PubMed Web of Science ®Google Scholar
• Breijyeh Z, Jubeh B, Karaman R. Resistance of Gram-negative bacteria to current antibacterial agents and approaches to resolve it. Mol. 2020;25(6):1340. doi:10.3390/MOLECULES25061340
   PubMed Web of Science ®Google Scholar
• Franco D, Calabrese G, Guglielmino SPP, Conoci S. Metal-based nanoparticles: antibacterial mechanisms and biomedical application. Microorg. 2022;10(9):1778. doi:10.3390/MICROORGANISMS10091778
   PubMed Web of Science ®Google Scholar
• Garcia-Rubio R, de Oliveira HC, Rivera J, Trevijano-Contador N. The fungal cell wall: candida, Cryptococcus, and Aspergillus species. Front Microbiol. 2020;10:492056. doi:10.3389/FMICB.2019.02993/BIBTEX
   Web of Science ®Google Scholar
• Carmo PHF, Garcia MT, Figueiredo-Godoi LMA, Lage ACP. Metal nanoparticles to combat Candida albicans infections: an update. Microorg. 2023;11(1):138. doi:10.3390/MICROORGANISMS11010138
   PubMed Web of Science ®Google Scholar
• Dizaj SM, Lotfipour F, Barzegar-Jalali M, Zarrintan MH, Adibkia K. Antimicrobial activity of the metals and metal oxide nanoparticles. Mater Sci Eng C. 2014;44:278–284. doi:10.1016/J.MSEC.2014.08.031
   PubMed Web of Science ®Google Scholar
• Qing Y, Cheng L, Li R, et al. Potential antibacterial mechanism of silver nanoparticles and the optimization of orthopedic implants by advanced modification technologies. Int J Nanomed. 2018;13:3311–3327. doi:10.2147/IJN.S165125
   PubMed Web of Science ®Google Scholar
• Su HL, Chou CC, Hung DJ, et al. The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay. Biomaterials. 2009;30(30):5979–5987. doi:10.1016/J.BIOMATERIALS.2009.07.030
   PubMed Web of Science ®Google Scholar
• Kaneko M, Togashi N, Hamashima H, Hirohara M, Inoue Y. Effect of farnesol on mevalonate pathway of Staphylococcus aureus. J Antibiot. 2011;64(8):547–549. doi:10.1038/ja.2011.49
   PubMed Web of Science ®Google Scholar
• Jabra-Rizk MA, Meiller TF, James CE, Shirtliff ME. Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility. Antimicrob Agents Chemother. 2006;50(4):1463–1469. doi:10.1128/AAC.50.4.1463-1469.2006
   PubMed Web of Science ®Google Scholar
• De-Carli AD, Sorgatto DL, Paim R, et al. Antimicrobial activity of tt-farnesol associated with an endodontic sealer against Enterococcus faecalis. G Ital Endod. 2021;35(1):10–16. doi:10.32067/GIE.2021.35.01.12
   Web of Science ®Google Scholar
• Abebe GM. The role of bacterial biofilm in antibiotic resistance and food contamination. Int J Microbiol. 2020;2020:1–10. doi:10.1155/2020/1705814
   Web of Science ®Google Scholar
• Shkodenko L, Kassirov I, Koshel E. Metal oxide nanoparticles against bacterial biofilms: perspectives and limitations. Microorganisms. 2020;8(10):1545. doi:10.3390/microorganisms8101545
   PubMed Web of Science ®Google Scholar
• Sahli C, Moya SE, Lomas JS, Gravier-Pelletier C, Briandet R, Hémadi M. Recent advances in nanotechnology for eradicating bacterial biofilm. Theranostics. 2022;12(5):2383–2405. doi:10.7150/thno.67296
   PubMed Web of Science ®Google Scholar
• Chen S, Xia J, Li C, Zuo L, Wei X. The possible molecular mechanisms of farnesol on the antifungal resistance of C. albicans biofilms: the regulation of CYR1 and PDE2. BMC Microbiol. 2018;18(1):1–14. doi:10.1186/S12866-018-1344-Z/TABLES/5
   PubMedGoogle Scholar
• Bandara HMHN, Herpin MJ, Kolacny D, Harb A, Romanovicz D, Smyth HDC. Incorporation of farnesol significantly increases the efficacy of liposomal ciprofloxacin against Pseudomonas aeruginosa biofilms in vitro. Mol Pharm. 2016;13(8):2760–2770. doi:10.1021/ACS.MOLPHARMACEUT.6B00360/ASSET/IMAGES/LARGE/MP-2016-00360P_0008.JPEG
   PubMed Web of Science ®Google Scholar
• Castelo-Branco DSCM, Riello GB, Vasconcelos DC, et al. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis. J Appl Microbiol. 2016;120(3):600–606. doi:10.1111/jam.13027
   PubMed Web of Science ®Google Scholar
• Öztürk B Y, Feyzullazade N, İ D, Şengel T. The investigation of in vitro effects of farnesol at different cancer cell lines. Microsc Res Tech. 2022;85(8):2760–2775. doi:10.1002/jemt.24125
   PubMed Web of Science ®Google Scholar
• Farnesol | C15H26O | CID 3327 - PubChem. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Farnesol. Accessed November 23, 2023.
   Google Scholar
• Zhang N, Xiong G, Liu Z. Toxicity of metal-based nanoparticles: challenges in the nano era. Front Bioeng Biotechnol. 2022;10:1001572. doi:10.3389/FBIOE.2022.1001572/BIBTEX
   PubMed Web of Science ®Google Scholar
• Sukhanova A, Bozrova S, Sokolov P, Berestovoy M, Karaulov A, Nabiev I. Dependence of nanoparticle toxicity on their physical and chemical properties. Nanoscale Res Lett. 2018;13(1):44. doi:10.1186/s11671-018-2457-x
   PubMed Web of Science ®Google Scholar
• R VG, M PV. Cellular interactions of zinc oxide nanoparticles with human embryonic kidney (HEK 293) cells. Colloids Surf B Biointerfaces. 2017;157:182–190. doi:10.1016/j.colsurfb.2017.05.069
   PubMed Web of Science ®Google Scholar